Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies, has transferred the upstream phase of the manufacturing process for LUMEVOQ, its gene ...

AGC Biologics will commence cell therapy process development and clinical manufacturing services at AGC Inc.’s Yokohama ...

In this episode of the Ask the Expert video series, Simona Guidi, Associate Director, Cell and Gene Therapies at ProPharma, ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

PORTLAND, IN, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, “Cell Culture Media Market by Type (Natural Media, Artificial Media), by Application ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision ...

AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s ...

CGT manufacturers need to get better at gathering process data to move manufacturing into the digital age according to a new study.

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...